Emmanouil Lymperis Selected Research

Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)

1/2017

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanouil Lymperis Research Topics

Disease

10	Neoplasms (Cancer) 07/2020 - 11/2015
3	Prostatic Neoplasms (Prostate Cancer) 03/2019 - 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017
1	Thyroid Neoplasms (Thyroid Cancer) 02/2016

Drug/Important Bio-Agent (IBA)

6	Neprilysin (Neutral Endopeptidase)IBA 07/2020 - 01/2016
5	Bombesin Receptors (Bombesin Receptor)IBA 07/2020 - 01/2017
4	Radioisotopes (Radionuclides)IBA 07/2020 - 02/2016
4	phosphoramidonIBA 07/2020 - 12/2016
4	Peptides (Polypeptides)IBA 07/2020 - 01/2016
3	GastrinsIBA 12/2016 - 11/2015
2	Biological ProductsIBA 03/2019 - 01/2018
2	BombesinIBA 03/2019 - 01/2019
2	68Ga-SB3IBA 03/2019 - 01/2017
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2016 - 02/2016
1	ProdrugsIBA 12/2016
1	Vasopeptidase InhibitorsIBA 12/2016
1	minigastrinIBA 02/2016
1	Cholecystokinin (Pancreozymin)IBA 11/2015

Therapy/Procedure

3	Therapeutics 01/2019 - 11/2015
2	Precision Medicine 01/2018 - 01/2017
1	Aftercare (After-Treatment) 07/2020